Table 3. Clinical factors for candida esophagitis on uni- and multivariable analysis (n = 733).
Clinical factors | CE (+) (n = 62) | CE (−) (n = 671) | Odds ratio (95% CI) | P |
Univariate analysis | ||||
Age (years) | ||||
<40 | 21 | 236 | 1 (referent) | |
≥40 | 41 | 435 | 1.06 (0.60–1.93) | 0.84 |
Sex | ||||
Female | 7 | 46 | 1 (referent) | |
Male | 55 | 625 | 0.58 (0.24–1.59) | 0.19 |
Sexual behavior | ||||
Heterosexual | 23 | 249 | 1 (referent) | |
MSM | 39 | 422 | 1.00 (0.57–1.80) | 1.00 |
CD4+ cell count (cells/μL) | ||||
>200 | 19 | 388 | 1 (referent) | |
100-199 | 4 | 134 | 0.61 (0.20–1.82) | |
<100 | 39 | 149 | 5.35 (2.99–9.55) | <0.01 |
HIV-RNA VL (copies/mL) | ||||
≤40 (normal range) | 10 | 376 | 1 (referent) | |
40<VL≤10,000 | 13 | 123 | 3.97 (1.70–9.29) | |
10,000<VL≤100,000 | 15 | 84 | 6.71 (2.91–15.5) | |
100,000< VL | 24 | 88 | 10.3 (4.73–22.2) | <0.01 |
History of HAART | ||||
Without | 30 | 158 | 1 (referent) | |
With | 32 | 513 | 0.33 (0.19–0.58) | <0.01 |
GI symptoms | ||||
Without | 35 | 435 | 1 (referent) | |
With | 27 | 236 | 1.42 (0.81–2.48) | 0.18 |
Multivariate analysis | ||||
CD4+ cell count (cells/μL) | ||||
>200 | 19 | 388 | 1 (referent) | |
100-199 | 4 | 134 | 0.43 (0.14–1.30) | |
<100 | 39 | 149 | 2.82 (1.46–5.46) | <0.01 |
HIV-RNA VL (copies/mL) | ||||
≤40 (normal range) | 10 | 376 | 1 (referent) | |
40<VL≤10,000 | 13 | 123 | 3.67 (1.54–8.74) | |
10,000<VL≤100,000 | 15 | 84 | 5.34 (2.24–12.7) | |
100,000< VL | 24 | 88 | 5.67 (2.39–13.4) | <0.01 |
Abbreviations: CE, Candida esophagitis; MSM, men who have sex with men; VL: viral load; HAART, highly active antiretroviral therapy.